• English (United Kingdom)
  • Italiano (Italia)
    • + Increase
    • - Decrease
    • = Normal
    • Default mode
    • High Contrast
    • High Contrast
    • Aa
Registro Tumori Veneto
  • Home
  • Chi siamo
    • Presentazione
    • Personale
    • Territorio e Popolazione
    • Normativa
    • News
    • Registro Mesoteliomi
      • Funzionamento
        • Metodi
        • Normativa
      • Attività
      • Personale
      • Pubblicazioni
  • Dati
    • Dati del Veneto
    • Dati per sede
    • Dati per ULSS
    • Video tutorial
  • Pubblicazioni
    • Scientifiche
    • Monografie
      • Per sede
      • Per età
      • Per area
    • Convegni
      • Comunicazioni orali
      • Poster
  • Links
    • Links
    • Area caricamento archivi
  • Contatti
Registro Tumori Veneto
  • Home
  • Chi siamo
    • Presentazione
    • Personale
    • Territorio e Popolazione
    • Normativa
    • News
    • Registro Mesoteliomi
      • Funzionamento
        • Metodi
        • Normativa
      • Attività
      • Personale
      • Pubblicazioni
  • Dati
    • Dati del Veneto
    • Dati per sede
    • Dati per ULSS
    • Video tutorial
  • Pubblicazioni
    • Scientifiche
    • Monografie
      • Per sede
      • Per età
      • Per area
    • Convegni
      • Comunicazioni orali
      • Poster
  • Links
    • Links
    • Area caricamento archivi
  • Contatti
  • Self-sampling to increase participation in cervical cancer screening: an RCT comparing home mailing, distribution in pharmacies, and recall letter

  • A 3-year interval is too short for re-screening women testing negative for human papillomavirus: a population-based cohort study

  • A prospective cohort study to identify biomarkers predicting the regression of grade 2 Cervical Intraepithelial Neoplasia. Study protocol

  • Cervical cancer screening in immigrant women in Italy: a survey on participation, cytology and histology results

  • Changes in cervical cancer incidence following the introduction of organized screening in Italy

  • Clinical relevance of partial HPV16/18 genotyping in stratifying HPV-positive women attending routine cervical cancer screening: a population-based cohort study

  • Combined use of cytology, p16 immunostaining and genotyping for triage of women positive for high-risk human papillomavirus at primary screening.

  • Determinants of p16/Ki-67 adequacy and positivity in HPV-positive women from a screening population

  • Developing evidence-based Multisociety Italian Guidelines for cervical cancer prevention: rationale, methods, and development process.

  • Esito clinico delle lesioni CIN2 trattate

  • Five-year risk of CIN3 after short-term HPV-DNA negativity in cytology-negative women: a population-based cohort study

  • HPV genotyping for the cross-sectional and longitudinal probability of developing CIN2

  • HPV vaccination in women treated for Cervical Intraepithelial Neoplasia grade 2 or 3: evidence-based recommendation from the Multisociety Italian Guidelines for cervical cancer prevention

  • Impact of variations in triage cytology interpretation on human papillomavirus-based cervical screening and implications for screening algorithms

  • Implementation of DNA-HPV primary screening in Italian cervical cancer screening programmes. Results of the MIDDIR Project

  • Indicators for monitoring screening programs with primary hpv test

  • Informed cytology for triaging HPV-positive women: substudy nested in the NTCC randomized controlled trial

  • Long-Term Clinical Outcome after Treatment for High-Grade Cervical Lesions: a Retrospective Monoinstitutional Cohort Study

  • Nuove Tecnologie per il cancro della Cervice 2 (NTCC2): disegno dello studio e andamento del reclutamento

  • Performance of HPV E6/E7 mRNA Assay as Primary Screening Test. Results from the NTCC2 Trial

Pagina 1 di 2

  • Inizio
  • Indietro
  • 1
  • 2
  • Avanti
  • Fine

Copyright © Registro Tumori Veneto 2018

Powered by ict4Life 

Privacy Policy

Joomla Templates by Joomla-Monster.com
Back to top